RxSight (RXST) Inventory Average (2021 - 2025)
RxSight (RXST) has disclosed Inventory Average for 5 consecutive years, with $32.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Inventory Average rose 44.28% year-over-year to $32.0 million, compared with a TTM value of $32.0 million through Dec 2025, up 44.28%, and an annual FY2025 reading of $27.8 million, up 40.86% over the prior year.
- Inventory Average was $32.0 million for Q4 2025 at RxSight, up from $28.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $32.0 million in Q4 2025 and bottomed at $8.4 million in Q1 2022.
- Average Inventory Average over 5 years is $18.4 million, with a median of $18.3 million recorded in 2023.
- The sharpest move saw Inventory Average surged 101.93% in 2023, then grew 7.92% in 2024.
- Year by year, Inventory Average stood at $10.0 million in 2021, then skyrocketed by 56.37% to $15.6 million in 2022, then rose by 16.42% to $18.2 million in 2023, then increased by 21.89% to $22.2 million in 2024, then surged by 44.28% to $32.0 million in 2025.
- Business Quant data shows Inventory Average for RXST at $32.0 million in Q4 2025, $28.6 million in Q3 2025, and $25.4 million in Q2 2025.